<?xml version="1.0" encoding="UTF-8"?>
<item xmlns="http://omeka.org/schemas/omeka-xml/v5" itemId="4904" public="1" featured="0" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://omeka.org/schemas/omeka-xml/v5 http://omeka.org/schemas/omeka-xml/v5/omeka-xml-5-0.xsd" uri="http://exhibits.library.stonybrook.edu/mfp/items/show/4904?output=omeka-xml" accessDate="2026-06-07T15:07:50+00:00">
  <fileContainer>
    <file fileId="2839">
      <src>http://exhibits.library.stonybrook.edu/mfp/files/original/3ea0e4ad8e48a635dec2f4cbb22db759.pdf</src>
      <authentication>10e69d8c307f89d374004fa9ba48512b</authentication>
      <elementSetContainer>
        <elementSet elementSetId="4">
          <name>PDF Text</name>
          <description/>
          <elementContainer>
            <element elementId="52">
              <name>Text</name>
              <description/>
              <elementTextContainer>
                <elementText elementTextId="103465">
                  <text>June 13, 1971
Dr. Jerome

Jaffe

Department of Psychiatry

University of Chicago
Chicago,

Illinois

Jerry,

Dear

The preliminary announcement of your appointment by the
President to lead the national effort against drug abuse was most
welcome here. I hope the appointment is made, and I wish you all
success. The undertaking is a great one and I am confident the nation
will follow your leadership willingly.

Since the reports in the New York Times last month of the
high rate of opiate use in our troops in Southeast Asia, I have become
additionally concerned about this horrendous aspect of this tragic war.
In considering the alternatives, I concluded that our clinical experience
with the antagonists (much of it unpublished) warranted some suggestions
which I shared with those authorities I could reach in Washington. I
write new in the hope that our experience may complement and re-enforce
your suggestions and recommendations.
aware

I consulting with the V.A. leaders in Washington, I became
were being entertained to rapidly return large numbers

thht pland

of addicted servicemen to their home communities, particularly to the
V.A. ceneters, for treatment programs focussed on methadone maintenance.
Such a rapid dispersion of the addicted drug users would be a tragic
error, for the V.A. centers are ill-equipped at present to care for
these men, and the users would provide multiple foci for local drug
use and experimentation as well as connections to enhance a drug traffic.
Such a course, based on dispersion, is the worst possible solution,
to homes
for
will return men who are unprepared for community

it

life,

without jobs and with inadequate counselling, and encourage the Spread
of addiction.

Every effort should be made to identify, detoxify and treat
in Asia, before they return home. One interesting suggestion
is to return the men to the States in slow ships, thus providing at
least 3—4 weeks of isolation, group therapy, counselling, and medication.

the

men

�“I1!-

new

..

Fun-["W—r

m

..
rmm

,v-w-u—m

m

Jaffe

Dr. Jerome

................ ...................June 13,
2

While I know every
and

traffic, educate the men,
tests, we would encourage

effort will

be made to

1971

restrict the

drug

identify users by urine and nalorphine
some specific applications of our esperience

with the antagonists. It now seems possible to provide prophylactic
programs, similar to the use of atabrine for malaria in an earlier war.
Opiate sependence has many of the characteristics of a contagious
disease, and I believe the daily administration of cyclazocine
would serve the same purpose today. Surely, id drug use is as widespread at the Times has reported, then an eXperiment in a small segment
of the 330,000 man army would be Iarranted.
Your experience with cyclazocine led to widespread
and in our early studies we confirmed your data.
The effects were exaggerated by the dosage schedules we then used. Since
January, 1970, we have inducted all our patients to 4 mg. cyclazocine
in 4 days with minimal discomfort, surely no greater than our patients

secondary

effects,

begin treatment with imipramine. For prophylaxis, 1—2
mg b.i.d.) should serve as an adequate deterrent.
The administration of a tablet twice a day at mealtime should serve
our purposes.
experience

who

each day (0.5-1.0

mg

-

have also discharged 6 patients from all care after 1.5 to
years on cyclazocine. These men remain drug-free, without 'craving'
We

4

after

3-9 months on no medication. Such a limited experience is
and not decisive, but sufficient to encourage further
trials. Surely, some military patients could be randomly assigned to
the antagonists, and were this experiment done carefully, an adequate
sample could be provided in a very short time. The men would have
similar histories of drug use, conditions of treatment and living,
etc. to those assigned to other regimens. Such an experiment would

interesting

answer many questions not only for the military, but for the nation as

well.

,
u...

In our discussions, and in the press, you have repeatedly
suggested that with the limited funds at your disposal in Illinois,
methadone was the treatment of choice. I agreed then, and I agree
today, that methadone provides the best answer for today. With
the crisin in Viet-Nam and the availability of funds from the military,
the V.A., and the P.H.S., surely the extensive clinical trials we
discussed should be undertaken as a logical back~up to the other programs

which you

will encourage.

For more than two years, I have supported and encoyraged
studies of the antagonists. As a national leader, I know you
will accept the repponsibility of leading the effort without the
parochialism so sadly evinced during the past few years by all of us.
I am delighted with your appointment, and I am encouraged that now I
can again turn my attentions to my laboratory studies.
expanded

With

all best

wishes for your personal success, I remain,
Most
Max

sincerely yours,
Fink,

M.D.

Professor of Psychiatry

�</text>
                </elementText>
              </elementTextContainer>
            </element>
          </elementContainer>
        </elementSet>
      </elementSetContainer>
    </file>
  </fileContainer>
  <collection collectionId="1">
    <elementSetContainer>
      <elementSet elementSetId="1">
        <name>Dublin Core</name>
        <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
        <elementContainer>
          <element elementId="50">
            <name>Title</name>
            <description>A name given to the resource</description>
            <elementTextContainer>
              <elementText elementTextId="1">
                <text>Correspondence</text>
              </elementText>
            </elementTextContainer>
          </element>
        </elementContainer>
      </elementSet>
    </elementSetContainer>
  </collection>
  <itemType itemTypeId="1">
    <name>Text</name>
    <description>A resource consisting primarily of words for reading. Examples include books, letters, dissertations, poems, newspapers, articles, archives of mailing lists. Note that facsimiles or images of texts are still of the genre Text.</description>
  </itemType>
  <elementSetContainer>
    <elementSet elementSetId="1">
      <name>Dublin Core</name>
      <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
      <elementContainer>
        <element elementId="50">
          <name>Title</name>
          <description>A name given to the resource</description>
          <elementTextContainer>
            <elementText elementTextId="49034">
              <text>Correspondence to: Jaffe, Jerome H.</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="51">
          <name>Type</name>
          <description>The nature or genre of the resource</description>
          <elementTextContainer>
            <elementText elementTextId="49035">
              <text>Text</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="43">
          <name>Identifier</name>
          <description>An unambiguous reference to the resource within a given context</description>
          <elementTextContainer>
            <elementText elementTextId="49036">
              <text>mfp-05-00-025-5-315</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="40">
          <name>Date</name>
          <description>A point or period of time associated with an event in the lifecycle of the resource</description>
          <elementTextContainer>
            <elementText elementTextId="49037">
              <text>1971 </text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="39">
          <name>Creator</name>
          <description>An entity primarily responsible for making the resource</description>
          <elementTextContainer>
            <elementText elementTextId="49038">
              <text>&lt;a title="Fink, Max, 1923-" href="http://id.loc.gov/authorities/names/n79039548" target="_blank"&gt;Fink, Max, 1923-&lt;/a&gt;</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="49">
          <name>Subject</name>
          <description>The topic of the resource</description>
          <elementTextContainer>
            <elementText elementTextId="49039">
              <text>Correspondence -- Correspondence</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="46">
          <name>Relation</name>
          <description>A related resource</description>
          <elementTextContainer>
            <elementText elementTextId="49040">
              <text>The Max Fink Collection</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="41">
          <name>Description</name>
          <description>An account of the resource</description>
          <elementTextContainer>
            <elementText elementTextId="49041">
              <text/>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="47">
          <name>Rights</name>
          <description>Information about rights held in and over the resource</description>
          <elementTextContainer>
            <elementText elementTextId="49042">
              <text>&lt;a title="IN COPYRIGHT - EDUCATIONAL USE PERMITTED" href="http://rightsstatements.org/vocab/InC-EDU/1.0/" target="_blank"&gt;IN COPYRIGHT - EDUCATIONAL USE PERMITTED&lt;/a&gt;</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="48">
          <name>Source</name>
          <description>A related resource from which the described resource is derived</description>
          <elementTextContainer>
            <elementText elementTextId="49043">
              <text>Special Collections and University Archives, University Libraries. Stony Brook University Libraries (State University of New York).</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="44">
          <name>Language</name>
          <description>A language of the resource</description>
          <elementTextContainer>
            <elementText elementTextId="79106">
              <text>en-US</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="42">
          <name>Format</name>
          <description>The file format, physical medium, or dimensions of the resource</description>
          <elementTextContainer>
            <elementText elementTextId="85667">
              <text>application/pdf</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="45">
          <name>Publisher</name>
          <description>An entity responsible for making the resource available</description>
          <elementTextContainer>
            <elementText elementTextId="92228">
              <text/>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="37">
          <name>Contributor</name>
          <description>An entity responsible for making contributions to the resource</description>
          <elementTextContainer>
            <elementText elementTextId="98789">
              <text/>
            </elementText>
          </elementTextContainer>
        </element>
      </elementContainer>
    </elementSet>
  </elementSetContainer>
  <tagContainer>
    <tag tagId="4">
      <name>Correspondence</name>
    </tag>
  </tagContainer>
</item>
